Ozempic (semaglutide) and Mounjaro (tirzepatide) are the two most popular GLP-1 medications for weight loss and diabetes management. While both are highly effective, they work differently and produce different results.
Key Differences
| Feature | Ozempic | Mounjaro |
|---|---|---|
| Mechanism | GLP-1 only | GLP-1 + GIP dual |
| Avg Weight Loss | ~15% | ~20-25% |
| Max Dose | 2mg | 15mg |
Which Should You Choose?
Consider Ozempic If:
- • Your insurance covers it but not Mounjaro
- • You prefer longer track record of data
- • Cost is a significant factor
Consider Mounjaro If:
- • Maximizing weight loss is your goal
- • You haven't responded well to semaglutide
- • You have significant insulin resistance
The Bottom Line
Both Ozempic and Mounjaro are highly effective. Mounjaro generally produces more weight loss (~20-25% vs ~15%), but both transform lives. Your choice may depend on insurance coverage, availability, and your personal health goals.